Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Tejpar

Showing results (11-20 of 232) with videos related to

Pageof 24
Sort By:
Journal of Gastrointestinal Oncology|July 20, 2012
How to overcome resistance to therapy?Camilla Qvortrup, Sabine Tejpar, Per Pfeiffer
Journal of the National Cancer Institute|March 23, 2010
Re: Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancerNicola Normanno, Sabine Tejpar, Fortunato Ciardiello
The Oncologist|July 10, 2012
Overcoming resistance to antiangiogenic therapiesSabine Tejpar, Hans Prenen, Massimiliano Mazzone
The New England Journal of Medicine|February 25, 2009
K-ras mutations and cetuximab in colorectal cancerWendy De Roock, Diether Lambrechts, Sabine Tejpar
The Lancet. Oncology|November 28, 2009
Improved first-line chemotherapy: a better chance for surgery?Sabine Tejpar, Eric Van Cutsem, Rene Adam
Cancer Cell|February 11, 2025
Immunosensitivity cuts across mismatch repair status in colorectal cancerAllyson Moraig Peddle, Gertjan Rasschaert, Sabine Tejpar
Seminars in Oncology|February 24, 2005
Oral capecitabine: bridging the Atlantic divide in colon cancer treatmentEric Van Cutsem, Chris Verslype, Sabine Tejpar
Journal of Plastic Surgery and Hand Surgery|June 21, 2011
Improved postoperative outcome of segmental fasciectomy in Dupuytren disease by insertion of an absorbable cellulose implantIlse Degreef, Sabine Tejpar, Luc De Smet
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
New strategies for treatment of KRAS mutant metastatic colorectal cancerHans Prenen, Sabine Tejpar, Eric Van Cutsem
European Journal of Cancer (Oxford, England : 1990)|September 25, 2009
Impact of molecular markers on treatment selection in advanced colorectal cancerHans Prenen, Sabine Tejpar, Eric Van Cutsem
Pageof 24

Showing results (11-20 of 232) with videos related to

Sort By:
Pageof 24
Journal of Gastrointestinal Oncology|July 20, 2012
How to overcome resistance to therapy?Camilla Qvortrup, Sabine Tejpar, Per Pfeiffer
Journal of the National Cancer Institute|March 23, 2010
Re: Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancerNicola Normanno, Sabine Tejpar, Fortunato Ciardiello
The Oncologist|July 10, 2012
Overcoming resistance to antiangiogenic therapiesSabine Tejpar, Hans Prenen, Massimiliano Mazzone
The New England Journal of Medicine|February 25, 2009
K-ras mutations and cetuximab in colorectal cancerWendy De Roock, Diether Lambrechts, Sabine Tejpar
The Lancet. Oncology|November 28, 2009
Improved first-line chemotherapy: a better chance for surgery?Sabine Tejpar, Eric Van Cutsem, Rene Adam
Cancer Cell|February 11, 2025
Immunosensitivity cuts across mismatch repair status in colorectal cancerAllyson Moraig Peddle, Gertjan Rasschaert, Sabine Tejpar
Seminars in Oncology|February 24, 2005
Oral capecitabine: bridging the Atlantic divide in colon cancer treatmentEric Van Cutsem, Chris Verslype, Sabine Tejpar
Journal of Plastic Surgery and Hand Surgery|June 21, 2011
Improved postoperative outcome of segmental fasciectomy in Dupuytren disease by insertion of an absorbable cellulose implantIlse Degreef, Sabine Tejpar, Luc De Smet
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2010
New strategies for treatment of KRAS mutant metastatic colorectal cancerHans Prenen, Sabine Tejpar, Eric Van Cutsem
European Journal of Cancer (Oxford, England : 1990)|September 25, 2009
Impact of molecular markers on treatment selection in advanced colorectal cancerHans Prenen, Sabine Tejpar, Eric Van Cutsem
Pageof 24